Marijuana Co of America, Inc. financial data

Symbol
MCOA on OTC
Industry
Medicinal Chemicals & Botanical Products
Location
633 W. 5 Th Street, Suite 2826, Los Angeles, CA
State of incorporation
UT
Fiscal year end
December 31
Former names
CONVERGE GLOBAL INC/CA (to 3/9/2009)
Latest financial report
10-Q - Q3 2022 - Nov 21, 2022

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 20.4 % +7.31%
Quick Ratio 2.35 % -12%
Debt-to-equity -409 % +31.6%
Return On Equity 636 % -60.7%
Return On Assets -206 % +36.7%
Operating Margin -273 % +75.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17B shares +157%
Common Stock, Shares, Outstanding 1.52B shares -76.2%
Common Stock, Value, Issued 101M USD +1487%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.5M USD +169%
Cost of Revenue 1.07M USD +136%
Selling and Marketing Expense 248K USD -52.7%
General and Administrative Expense 2.32M USD +5.81%
Operating Income (Loss) -4.09M USD +34.2%
Nonoperating Income (Expense) -8.87M USD +1.34%
Net Income (Loss) Attributable to Parent -13M USD +14.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 831 USD -99.2%
Accounts Receivable, after Allowance for Credit Loss, Current 240K USD +58.2%
Inventory, Net 181K USD -10.5%
Other Assets, Current 36.9K USD -80.3%
Assets, Current 459K USD -37.6%
Property, Plant and Equipment, Net 106K USD -13.4%
Goodwill 1.63M USD -44.2%
Assets 3.47M USD -43%
Accounts Payable, Current 998K USD +7.63%
Employee-related Liabilities, Current 334K USD
Accrued Liabilities, Current 577K USD +228%
Liabilities, Current 8.98M USD +106%
Liabilities 8.98M USD +106%
Accumulated Other Comprehensive Income (Loss), Net of Tax -31.7K USD
Retained Earnings (Accumulated Deficit) -107M USD -13.9%
Stockholders' Equity Attributable to Parent -5.51M USD -421%
Liabilities and Equity 3.47M USD -43%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -678K USD +29.5%
Net Cash Provided by (Used in) Financing Activities 822K USD -46.3%
Net Cash Provided by (Used in) Investing Activities -1.7K USD +16.3%
Common Stock, Shares Authorized 32B shares +113%
Common Stock, Shares, Issued 1.52B shares -76.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 140K USD -75.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 831 USD -99.2%
Payments to Acquire Property, Plant, and Equipment 1.7K USD -16.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13M USD -124%
Property, Plant and Equipment, Gross 150K USD +5.41%
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 89.6M USD +6.68%
Depreciation, Depletion and Amortization 51.1K USD +3570%
Interest Expense 4.62M USD +49.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%